Moxetumomab pasudotox-containing product in parenteral dose form 781157009
SNOMED CT code
| SNOMED code | 781157009 |
|---|---|
| name | Moxetumomab pasudotox-containing product in parenteral dose form |
| status | active |
| date introduced | 2019-01-31 |
| fully specified name(s) | Product containing moxetumomab pasudotox in parenteral dose form (medicinal product form) |
| synonyms | Moxetumomab pasudotox-containing product in parenteral dose form |
| attributes - group0 | |
| Has manufactured dose form | Parenteral dose form 385287007 |
| Plays role | Antineoplastic therapeutic role 773879000 |
| attributes - group1 | |
| Has active ingredient | Moxetumomab pasudotox 781124007 |
| parents | |
| children | Moxetumomab pasudotox only product in parenteral dose form 781158004 |
| hierarchies | a selection of possible paths SNOMED CT Concept 138875005Pharmaceutical / biologic product 373873005 Medicinal product 763158003 Product manufactured as parenteral dose form 440132002 Moxetumomab pasudotox-containing product in parenteral dose form 781157009 SNOMED CT Concept 138875005 Pharmaceutical / biologic product 373873005 Medicinal product 763158003 Medicinal product categorized by therapeutic role 763087004 Antineoplastic agent 27867009 Monoclonal antibody antineoplastic agent 1144210000 Moxetumomab pasudotox-containing product 781155001 Moxetumomab pasudotox-containing product in parenteral dose form 781157009 |
| ancestors | sorted most to least specific
|
| cpt crosswalks | |
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com